Clinical trial

Trifecta Research Study

Axial Therapeutic ResearchActive, not recruitingStarted Aug 1, 202252 enrolledUnited StatesNCT07717866

Abstract

This observational study evaluates the impact of Ibogaine-Magnesium (IM), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), Magnetic e-Resonance Therapy (MeRT), and Physiological Supplementation (PS) on posttraumatic stress disorder (PTSD) and traumatic brain injury-related cognitive symptoms among Special Operations Forces (SOF) combat veterans.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

IbogaineDepressionPTSD

Keywords

psychedelicMeRTspecial operationsveteranTBITMSsuicidal ideationsuicidalityPTSD - Post Traumatic Stress DisorderCognitive DysfunctionBrain InjuryDepression - Major Depressive DisorderSuicidal Ideation

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023

ArticlePsilocybin

Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.

Portes MAM, Bertoglio LJ

Europe PMC2026

PreprintKetamine

Blood biomarker changes in response to low-dose oral ketamine treatment in adults with major depressive disorder (MDD) and post-traumatic stress disorder (PTSD)

Braxton AM, Driver C, Hermens DF +1

Europe PMC2026